Bcl-2 proto-oncogene prevents apoptosis in many conditions. First dete
cted in lymphomas, it has been also described in non-lymphoid tissues.
The immunohistochemical distribution of bcl-2 protein in 100 neuroepi
thelial tumors is presented. Bcl-2 was positive in some neurons of nor
mal nervous tissue, in reactive astrocytes and variably in all neuroep
itelial tumors. The reaction product was either diffuse or granular, d
ue to bcl-2 protein localization on cytoplasmic, nuclear and mitochond
rial membranes. The positivity was high in medulloblastomas and in ast
rocytic tumors. In the latter, the strongest staining was found in cel
ls retaining the astrocytic aspect. Oligodendroglial cells were minima
lly stained. No correlation of bcl-2 staining with survival was found
in each tumor type. The interpretation of the results is based on the
one side on the constitutive role played by bcl-2 in the nervous tissu
e and its neoplastic derivatives. On the other side, in tumors bcl-2 a
cts by preventing tumor cells from undergoing apoptosis. Bcl-2 express
ion in brain tumors, therefore, receives a dual interpretation. For th
is reason and for the lacking of correlation with survival, bcl-2 expr
ession cannot be regarded as a prognostic factor.